EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Insolvency/Restructure of
Company
Marinomed Biotech AG: Court opens restructuring proceedings without
self-administration
14-Aug-2024 / 15:35 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the
Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS
Group AG.
The issuer is solely responsible for the content of this announcement.
══════════════════════════════════════════════════════════════════════════
Korneuburg, Austria, 14. August 2024 – Marinomed Biotech AG (VSE:MARI)
announces that on August 14, 2024, the Regional Court of Korneuburg opened
restructuring proceedings without self-administration at the request of
Marinomed Biotech AG. The Company expects trading of Marinomed shares to
resume soon and a switch to the standard market continuous on the Vienna
Stock Exchange.
+++ End of ad-hoc announcement +++
End of Inside Information
══════════════════════════════════════════════════════════════════════════
14-Aug-2024 CET/CEST News transmitted by EQS Group AG. www.eqs.com
══════════════════════════════════════════════════════════════════════════
Language: English
Company: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
Phone: +43 2262 90300
E-mail: office@marinomed.com
Internet: www.marinomed.com
ISIN: ATMARINOMED6
WKN: A2N9MM
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt,
Munich, Stuttgart, Tradegate Exchange; Vienna Stock Exchange
(Official Market)
EQS News ID: 1968247
End of Announcement EQS News Service
1968247 14-Aug-2024 CET/CEST
